Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

7.37USD
15 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.37
Open
$7.45
Day's High
$7.46
Day's Low
$7.28
Volume
980,612
Avg. Vol
85,286
52-wk High
$9.22
52-wk Low
$3.76

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
FY 2015 Dec '15 2.78 -0.053
Mar '15 2.73 -0.046
Dec
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 8.56 22.00 0.00 10.68
Quarter Ending Mar-18 5 11.43 22.00 4.00 11.47
Year Ending Dec-17 7 41.50 51.00 33.60 22.49
Year Ending Dec-18 7 52.40 88.00 32.50 37.69
Earnings (per share)
Quarter Ending Dec-17 6 -0.23 -0.09 -0.32 -0.34
Quarter Ending Mar-18 5 -0.21 -0.10 -0.25 -0.23
Year Ending Dec-17 6 -0.75 -0.61 -0.94 -1.17
Year Ending Dec-18 6 -0.81 -0.39 -1.29 -1.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 44.03 100.68 5.40
Price to Book (MRQ) 3.33 13.50 5.38
Price to Tangible Book (MRQ) 3.35 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 62.37 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 973.48 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago 48.46 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.20 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -44.84 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 7.86 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -435.08 -- --
EBITD - 5 Yr. Avg -- -261.13 15.24
Operating Margin (TTM) -457.44 -556.69 7.76
Operating Margin - 5 Yr. Avg. -- -279.31 10.75
Pre-Tax Margin (TTM) -432.60 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.05 11.17
Net Profit Margin (TTM) -438.00 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 58,154 25,316,769 864,680,848
Net Income/Employee (TTM) -254,715 3,332,346 101,718,394
Receivable Turnover (TTM) 24.65 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.07 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.98 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -32.06 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -35.60 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.62 -11.77 20 53
13 Week 66.87 58.74 95 60
26 Week 43.16 32.28 84 69
52 Week 20.18 1.86 66 46
YTD 101.48 76.94 89 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 61.50%
# of Holders: 67
Total Shares Held: 57,620,832
3 Mo. Net Change: 2,664,498
# New Positions: 16
# Closed Positions: 6
# Increased Positions: 38
# Reduced Positions: 20
# Net Buyers: 18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.